Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2002;55:710-714; doi:10.1136/jcp.55.9.710
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2002;55:710-714
© 2002 Journal of Clinical Pathology

CASE REPORT

A tumour with a neuroendocrine and papillary serous component: two or a pair?

S van Eeden1, P M Nederlof2, B G Taal3, G J A Offerhaus1 and M-L F van Velthuysen2

1 Academic Medical Center, Department of Pathology, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
2 Department of Pathology, Het Nederlands Kankerinstituut/Antoni van Leeuwenhoek Ziekenhuis, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
3 Department of Gastroenterology, Het Nederlands Kankerinstituut/Antoni van Leeuwenhoek Ziekenhuis

Correspondence to:
Correspondence to:
Dr S van Eeden, Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands;
S.vaneeden{at}amc.uva.nl

ABSTRACT

Aims: To examine the clonal origin of a tumour, made up of a neuroendocrine component and a papillary serous component by comparing the pattern of loss of heterozygosity (LOH) and the immunohistochemical protein expression of both components.

Methods/Results: A 70 year old woman, known to have a metastasised neuroendocrine carcinoma, underwent resection of the distal part of the ileum because of obstruction by a mesenterial mass. The macroscopically homogeneous mesenterial mass consisted histologically of an admixture of a neuroendocrine component and a papillary serous carcinoma. Loss of heterozygosity (LOH) analysis of both components with a panel of 15 polymorphic microsatellite markers showed a distinctive pattern of LOH, and both components showed LOH on chromosome 4q and 17, but involving different alleles at the same locus. Moreover, both components showed different immunohistochemical staining patterns for neuroendocrine markers, cytokeratin 7, carcinoembryonic antigen, and CA125.

Conclusion: Both LOH analysis of the neuroendocrine and papillary serous components of this tumour and the immunohistochemical profile of both components are consistent with a different clonal origin. The tumour is probably a collision tumour, in which the papillary serous carcinoma must have been of peritoneal origin because necropsy revealed a normal uterus and normal ovaries.

Keywords: collision tumour; neuroendocrine carcinoma; papillary serous carcinoma; peritoneum; loss of heterozygosity; immunohistochemistry

Abbreviations: CEA, carcinoembryonic antigen; LOH, loss of heterozygosity; PCR, polymerase chain reaction


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • de Jong, D., Glas, A. M., Boerrigter, L., Hermus, M.-C., Dalesio, O., Willemse, E., Nederlof, P. M., Kersten, M. J. (2003). Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features. Blood 102: 324-327 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs